AIM WINNERS & LOSERS: Futura Medical rises on financing transaction
AIM WINNERS & LOSERS: Futura Medical rises on financing transaction
Read moreMon, 17th Feb 2020 15:25
AIM WINNERS & LOSERS: Futura Medical rises on financing transaction
Read moreAngle Shares Jump On Recent Parsortix System Research Results
Read moreIN BRIEF: Angle Says Athens University Study Shows Value Of Parsortix
Read moreTRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash
Read moreAngle Reports Parsortix System Can Isolate Circulating Tumour Cells
Read moreLONDON AIM WINNERS & LOSERS: Sabien Sinks On Ptarmigan Deal Withdrawal
Read moreDIRECTOR DEALINGS: Angle Chair And Finance Director Buys 60,000 Shares
Read moreUK EARNINGS SUMMARY: Gfinity Continues Review Including Possible Sale
Read moreUPDATE: Angle Successfully Raises GBP20 Million In Placing
Read moreIN BRIEF: Angle To Raise GBP20 Million To Fund Operations
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreIN BRIEF: Angle Says FDA Accepts Parsotix Submission For Breast Cancer
Read more(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the US Food and Drug Administration (FDA) has completed its administrative review, and accepted the company's submission for substantive review.
Read moreIN BRIEF: Angle Submits US FDA De Novo Application For Parsortix
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read more